News
08.06.2026
Save the Date: GBAICTI Regional Clinical Trial Conference 2026
Join us as GBAICTI convenes leaders across the clinical research ecosystem to advance collaboration and innovation.
View More
28.05.2026
GBAICTI Welcomes Danish Health and Life Sciences Delegation
The Greater Bay Area International Clinical Trial Institute (GBAICTI) was pleased to host a delegation from the Royal Danish Consulate General in Guangzhou for a site visit to the Hetao area.
View More
13.05.2026
Showcasing Hong Kong’s Clinical Trial Strengths at Asia Summit on Global Health 2026
The Greater Bay Area International Clinical Trial Institute (GBAICTI) participated in the Asia Summit on Global Health held from 11–12 May 2026, joining global healthcare leaders and industry stakeholders to exchange insights and explore opportunities for collaboration in advancing innovation across the life sciences sector.
View More
05.05.2026
Accelerating Clinical Trials Together: CRO Partners Connect
The Greater Bay Area International Clinical Trial Institute (GBAICTI) held our inaugural Hong Kong CRO Partners Connect this week, bringing together 10 leading CROs to exchange views on strengthening Hong Kong’s clinical trial ecosystem.
View More
24.04.2026
Shaping the Future of Clinical Excellence in Hong Kong: Investigator Site Training Survey
As part of GBAICTI's mission to provide one-stop support for clinical trials and develop regional talent, we are establishing the International Clinical Trial Academy (ICTA).
We are inviting you to take 10-15 minutes for this survey to help us design trainings that best suit the industry's needs.
View More
15.04.2026
GBAICTI Hosts Seminar on Hong Kong Drug Registration Landscape
The Greater Bay Area International Clinical Trial Institute (GBAICTI) held a seminar on the Hong Kong drug registration landscape on 15 April 2026, bringing together industry stakeholders for an engaging exchange of insights on regulatory developments and clinical trial advancement in Hong Kong and the Greater Bay Area (GBA).
View More